The Effect on Vascular Reactivity Using the Erythropoeitin Alpha on Incident Peritoneal Dialysis Patients

NCT03286712 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease
Anemia
Complication of Peritoneal Dialysis

Interventions

DRUG: Renogen

Sponsor

National Kidney and Transplant Institute, Philippines